# A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen

> **NCT01486004** · PHASE1 · COMPLETED · sponsor: **Tibotec Pharmaceuticals, Ireland** · enrollment: 18 (actual)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** TMC435
- **DRUG:** Ovysmen

## Key facts

- **NCT ID:** NCT01486004
- **Lead sponsor:** Tibotec Pharmaceuticals, Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486004, "A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01486004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*